findmyKOL
Clinical trialNCT03542877CompletedPhase 2Interventional

Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

SponsorAcademic Thoracic Oncology Medical Investigators ConsortiumEnrollment44Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arizona

    Tucson, Arizona, United States

  • Kenneth Norris Jr. Comprehensive Cancer Center

    Los Angeles, California, United States

  • Universtiy of Colorado Denver

    Aurora, Colorado, United States

  • Lone Tree Health Center

    Lone Tree, Colorado, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • Jefferson Abington Hospital

    Abington, Pennsylvania, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • Swedish Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2018
Primary completion
19 Oct 2020
Completion
7 Mar 2022
Last update posted
15 Jul 2022
Registered enrollment
44
Registry id
NCT03542877

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.